Literature DB >> 17262200

The prevalence of ocular involvement in patients with inflammatory bowel disease.

Safiye Yilmaz1, Ebru Aydemir, Ahmet Maden, Belkis Unsal.   

Abstract

PURPOSE: The aim of this prospective randomized clinical study was to evaluate the prevalence of ocular involvement in patients with inflammatory bowel disease (IBD).
MATERIALS AND METHODS: We prospectively evaluated 116 patients who went to the gastroenterology clinic with endoscopically proven IBD between December 2001 and February 2005. All patients were examined for evidence of ocular manifestations of IBD. Twenty patients had Crohn's disease and 96 had ulcerative colitis. The examination consisted of slit-lamp examinations, tonometry, visual acuity, and indirect ophthalmoscopy.
RESULTS: The mean age of the 116 patients with IBD who were enrolled was 40.6 +/- 14.4 years (range 16 to 75). Twelve of 20 patients (60%) with Crohn's disease and 22 of 96 patients (22.92%) with ulcerative colitis had ocular involvement. The most common ocular findings were conjunctivitis (8.62%) and blepharitis (6.9%) followed by uveitis (5.17%), cataract (5.17%), and episcleritis (3.45%). Extraintestinal complications were seen in 12 (35.3%) of 34 patients with ocular involvement and in 16 (19.5%) of 82 patients without ocular involvement.
CONCLUSION: Because the ocular complaints of IBD patients are often nonspecific, it may be helpful to performed eye examinations as a routine component in the follow-up of these patients. It is well-known that early diagnosis and treatment of ocular involvement may prevent serious ocular complications that could be associated with significant visual morbidity. In addition, clinicians should be aware that some ocular diseases, such as uveitis and scleritis, might precede a diagnosis of ulcerative colitis or Crohn's disease.

Entities:  

Mesh:

Year:  2007        PMID: 17262200     DOI: 10.1007/s00384-007-0275-1

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  14 in total

1.  Ocular inflammation in Crohn's disease.

Authors:  J F Salmon; J P Wright; A D Murray
Journal:  Ophthalmology       Date:  1991-04       Impact factor: 12.079

2.  The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients.

Authors:  A J Greenstein; H D Janowitz; D B Sachar
Journal:  Medicine (Baltimore)       Date:  1976-09       Impact factor: 1.889

3.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Authors:  D Rachmilewitz
Journal:  BMJ       Date:  1989-01-14

4.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

5.  Ocular manifestations of inflammatory bowel disease.

Authors:  E A Petrelli; M McKinley; F J Troncale
Journal:  Ann Ophthalmol       Date:  1982-04

6.  Peripheral corneal infiltrates in inflammatory bowel disease.

Authors:  M F Schulman; A Sugar
Journal:  Ann Ophthalmol       Date:  1981-01

7.  Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease.

Authors:  S H Soukiasian; C S Foster; M B Raizman
Journal:  Am J Ophthalmol       Date:  1994-11-15       Impact factor: 5.258

8.  Primary, secondary and coincidental ocular complications of Crohn's disease.

Authors:  D L Knox; A P Schachat; E Mustonen
Journal:  Ophthalmology       Date:  1984-02       Impact factor: 12.079

Review 9.  Inflammatory bowel disease and the eye.

Authors:  Faruque D Ghanchi; Bjorn J Rembacken
Journal:  Surv Ophthalmol       Date:  2003 Nov-Dec       Impact factor: 6.048

10.  National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications.

Authors:  G B Rankin; H D Watts; C S Melnyk; M L Kelley
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

View more
  19 in total

1.  Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits.

Authors:  Sasha Taleban; Dalin Li; Stephan R Targan; Andrew Ippoliti; Steven R Brant; Judy H Cho; Richard H Duerr; John D Rioux; Mark S Silverberg; Eric A Vasiliauskas; Jerome I Rotter; Talin Haritunians; David Q Shih; Marla Dubinsky; Gil Y Melmed; Dermot P B McGovern
Journal:  J Crohns Colitis       Date:  2015-10-08       Impact factor: 9.071

2.  Choroidal neovascularization in a patient with ulcerative colitis.

Authors:  Kenji Ishihara; Akitaka Tsujikawa; Yuko Yodoi; Takanori Kameda; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

3.  Orbital pseudotumour as a presentation of paediatric ulcerative colitis.

Authors:  Justin Hung Tiong Tan; Hui Ping Chu; Lena Das; Thaschawee Arkachaisri
Journal:  Singapore Med J       Date:  2014-10       Impact factor: 1.858

4.  Concurrent macular oedema and optic neuritis in Crohn's disease with varied response to steroids.

Authors:  Adeela Malik; Rosina H Zakri; Zenobia Sheikh; Zaid Shalchi; Rashid Zia; David J Schultz
Journal:  BMJ Case Rep       Date:  2010-04-05

Review 5.  Similarities and differences between Behçet's disease and Crohn's disease.

Authors:  Veli Yazısız
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

6.  More than meets the eye.

Authors:  Rebecca L Manno; Stuart M Levine; Allan C Gelber
Journal:  Semin Arthritis Rheum       Date:  2010-06-11       Impact factor: 5.532

7.  The association between pulmonary function impairment and colon inflammation in ulcerative colitis patients: A scientific basis for exterior-interior correlation between lung and large intestine.

Authors:  Jian-Yun Wang; Xin-Yue Wang; Hua-Yang Wu; Hui-Yi Sun; Da-Ming Liu; Wen Zhang; Chen-Xi Jin; Shuo-Ren Wang
Journal:  Chin J Integr Med       Date:  2014-06-18       Impact factor: 1.978

8.  Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials.

Authors:  Lucas Guillo; Ferdinando D'Amico; Mélanie Serrero; Karine Angioi; Damien Loeuille; Antonio Costanzo; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-08-10       Impact factor: 4.623

Review 9.  Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease.

Authors:  James T Rosenbaum
Journal:  Clin Rheumatol       Date:  2015-05-08       Impact factor: 2.980

Review 10.  A Role for Folate in Microbiome-Linked Control of Autoimmunity.

Authors:  Christine Mölzer; Heather M Wilson; Lucia Kuffova; John V Forrester
Journal:  J Immunol Res       Date:  2021-05-19       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.